595 filings
Page 8 of 30
EFFECT
od0coa 45zqvh
5 Jun 17
Notice of effectiveness
12:00am
CORRESP
p7dqgw
2 Jun 17
Correspondence with SEC
12:00am
UPLOAD
7qle1od9
23 May 17
Letter from SEC
12:00am
8-K
pwu6s c0s4
22 May 17
Elite Pharmaceuticals Acquires Trimipramine ANDA
12:00am
D
zw3o04r9x9ivo
10 May 17
$41.6M in equity, sold $800K, 1 investor
12:00am
8-K
38dnv77fjjjs 6stew
2 May 17
Entry into a Material Definitive Agreement
12:00am
8-K/A
lzgrwb9p27
1 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
7pz33v6x1 fejd4li
28 Apr 17
Entry into a Material Definitive Agreement
12:00am
424B3
pqavi4sk tspe4vroc
9 Feb 17
Prospectus supplement
12:00am
8-K
721ctlasoh pai
9 Feb 17
Elite Pharmaceuticals, Inc. Reports Results for Third Quarter of Fiscal Year 2017
12:00am
CT ORDER
r1x6kk
22 Dec 16
Confidential treatment order
12:00am
8-K
p16s3c10lc2 wf
22 Dec 16
Elite Provides Update on SequestOxâ„¢ New Drug Application
12:00am
424B3
otvt333uf48a1v584fqr
9 Nov 16
Prospectus supplement
12:00am
8-K
24qi5zx
1 Sep 16
Entry into a Material Definitive Agreement
12:00am